Samuel Herbert

BBI Diagnostics Group 2 Plc provides diagnostic tests and materials. It offers a portfolio of products and services that are provided to the diagnostic, healthcare, research, defense, and food industries. The company was founded on October 22, 2013 and is headquartered in Bedford, the United Kingdom.

Part of Triley Bidco Ltd., Idis Group Holdings Ltd. is a holding British company. The company is based in Burton-on-Trent, UK. Founded in 2005, Idis Group Holdings operates as a holding company.

Triley Bidco Ltd. is an investment holding British company founded in 2021. The private company is based in London, UK. and has a global presence of subsidiaries in several regions. Triley Bidco functions as an investment holding company.

Part of Triley Bidco Ltd., Clinigen Holdings Ltd. develops pharmaceutical products. The company is based in Burton-on-Trent, UK. Clinigen Holdings was founded in 2017.

Part of Iovance Biotherapeutics, Inc., Clinigen SP Ltd. is a British pharmaceutical company that manufactures and sells pharmaceutical products. The company is based in Burton-On-Trent, UK. The company was founded in 2013. Clinigen was acquired by Iovance Biotherapeutics, Inc. from Clinigen Holdings Ltd. on May 18, 2023 for $264.04 million.

Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom.

Idis Ltd. supplies pharmaceuticals and allied services to the healthcare industry. the company was founded by Crane Michael and Gould Amanda in 1987 and is headquartered in Weybridge, The united kingdom

Macrotarg Ltd. is a biotechnology research and British experimental development company founded in 2007. The private company is based in Winnersh, UK.

AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada.

Transine Therapeutics Ltd. is an RNA platform company based in Cambridge, UK. The British company is developing a novel class of therapeutic RNAs called SINEUPs, which can upregulate protein expression with a superior level of control and specificity across an unprecedented range of diseases and applications. The company's proprietary technology allows them to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. The SINEUP platform boosts the expression of almost any chosen target protein by binding precisely to the mRNA that encodes it and enhancing its translation. This technology massively extends the druggable proteome and represents an entirely new mechanism of action, ideally suited to address currently hard-to-treat diseases. The company was founded in 2018 by Stefano Gustincich and Piero Carninci. Jan Thirkettle has been the CEO of the company since 2021.

Ratos AB (Private Equity) (Ratos) is a private equity operating division of Ratos AB. The firm is headquartered in Stockholm, Sweden.

Mobile Climate Control Group Holding AB provides custom engineered heating, ventilating, and air conditioning systems. The firm develops, manufactures, and sells customized climate control systems for vehicles. It targets customer segments: bus manufacturers for transit, intercity, coach, shuttle, and school; utility vehicle manufactures for fire trucks, garbage and concrete trucks, electrical, and conventional delivery vehicles; off road vehicle manufacturers for construction, mining, material handling, forest and agriculture applications; as well as military vehicle manufacturers. The company was founded in 1975 and is headquartered in Stockholm, Sweden.

Ledil Oy offers lighting and electronics products and custom solutions. Its product range includes lenses, reflectors, and combinations of various light-emitting diode lights. The firm provides street and area lightning, indoor architectural and general lightning, outdoor architectural, industrial, hospital and security lightning. The company was founded by Hannu Hukkanen and Tomi Mikael Kuntze in 2002 and is headquartered in Salo, Finland.

Linear Diagnostics Ltd. operates as a diagnostics company based on a novel technology that allows wide range of molecular diagnostics tests to be carried out using a simple optical system. It specializes in molecular diagnostics, novel technology and optical detection. The company was founded by Matt Hicks in 2011 and is headquartered in Birmingham, the United Kingdom.

Zeneca Pharmaceuticals manufactures medicines.

Mehiläinen Oy provides healthcare and social care services. It offers physician services, diagnostics, surgeries, dental and emergency care, as well as home and residential care services for the elderly and disabled, mental health rehabilitation, and child welfare services. The company serves private, insurance, corporate, and municipal customers. Mehiläinen was founded by Reguel Lofqvist, Akseli Koskimies, Walter Sipila, and K. F. Hirvisalo on November 6, 1909 and is headquartered in Helsinki, Finland.

Ashfield Healthcare Communications LLC provides healthcare information and communication solutions. Its services include support for data-driven clinical publications, strategic consulting, thought leader programs, advisory boards, disease-state education, live educational events and international congresses, web portals and promotional communications. The company was founded in 1972 and is headquartered in Lyndhurst, NJ.

Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom.

Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland.

Mindmaze, Inc. operates as a computing platform that captures brain activity. The firm develops medical virtual reality products for neural sicknesses. The firm offers MindMotion PRO, is FDA-cleared to bring 3D virtual environment therapy for neuro rehabilitation to patients. The company was founded by Tej Tadi in 2012 and is headquartered in San Francisco, CA.

Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA.

Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates.

Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France.

EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom.

KPMG Audit Plc provides accounting services. The company was founded in 1995 and is headquartered in London, GB.

Sustrans Ltd. operates as a charity that provides travel choices. It connects people and places, liveable neighbourhoods, transform the school run and delivers commute. The company was founded in 1977 and is headquartered in Bristol, the United Kingdom.

London Stock Exchange Plc, operates as a stock exchange. It offers capital market, trading, information, derivatives, studio, regulatory, enhanced, connectivity, telephone network, reference and historical data, historic price, corporate action, trade data, valuation data, broker ranking, matching and reconciliation. The company was founded in 1571 and is headquartered in London, the United Kingdom.

BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom.

Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom.